SIMPLIFY HEALTH CARE ETF(PINK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PINK SIMPLIFY HEALTH CARE ETF

盘前交易 09-02 08:26:03 EDT

39.27

-0.04

-0.10%

最高39.41	最低39.18	成交量4.39万
今开39.35	昨收39.31	日振幅0.59%
总市值3.74亿	流通市值3.74亿	总股本952.50万
成交额172.37万	换手率0.46%	流通股本952.50万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PINK","market":"US","secType":"STK","nameCN":"SIMPLIFY HEALTH CARE ETF","latestPrice":39.2693,"timestamp":1788292800000,"preClose":39.31,"halted":0,"volume":43873,"delay":0,"changeRate":-0.0010353599592979156,"floatShares":9525001,"shares":9525001,"eps":0,"marketStatus":"盘前交易","change":-0.0407,"latestTime":"09-02 08:26:03 EDT","open":39.35,"high":39.41,"low":39.18,"amount":1723703,"amplitude":0.005851,"askPrice":44.07,"askSize":100,"bidPrice":35.81,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":39.2693,"sharesOutstanding":7975001,"nav":39.2322,"aum":373681696.87,"dividendRate":0.006415,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.27,"preClose":39.2693,"latestTime":"16:11 EDT","volume":56,"amount":2195.2716,"timestamp":1788293468699,"change":0.0007,"changeRate":0.000018,"amplitude":0},"volumeRatio":1.0352484274192828,"impliedVol":0.0537,"impliedVolPercentile":0.1275},"requestUrl":"/m/hq/s/PINK","defaultTab":"news","newsList":[{"id":"2664882140","title":"Hims & Hers在澳大利亚推出GLP-1减肥药及治疗方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882140","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664882140?lang=zh_cn&edition=full","pubTime":"2026-09-01 10:10","pubTimestamp":1788228656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LLYX","RSPH","NVOC","FHLC","IYH","ELIL","PINK","ELIS","THNR","JDOC","CURE","NVOH","OZEM","XLVI","FXH","LLII","MEDI","NVOX","PJP","TRUH","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006809","title":"不止步于“减肥药之王” 礼来(LLY.US)拟最高28.8亿美元收购Merida加码自身免疫赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006809","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663006809?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来计划以高达28.8亿美元的现金收购Merida Biosciences Inc.，加码自身免疫与过敏疾病领域，以摆脱对减重和糖尿病两大支柱业务的过度依赖——正是这两大市场助其登顶全球药企市值之巅。今年以来，礼来掀起并购狂潮，迄今已宣布的交易总额超过200亿美元。5月，礼来还达成协议，以最高38亿美元收购三家疫苗研发企业。截至发稿，礼来盘前跌0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLVI","FHLC","NVOC","THNR","CURE","FXH","NVOX","PINK","PJP","NBDS","MEDI","IYH","NVOH","RSPH","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006800","title":"不止步于“减肥药之王” 礼来(LLY.US)拟最高28.8亿美元收购Merida加码自身免疫赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663006800?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XLVI","FXH","MEDI","NVOH","PJP","CURE","NVOC","IYH","TRUH","FHLC","PINK","NBDS","RSPH","THNR","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662376416","title":"中国减肥药研发公司德睿智药称AI助力研发时间缩短一半","url":"https://stock-news.laohu8.com/highlight/detail?id=2662376416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662376416?lang=zh_cn&edition=full","pubTime":"2026-08-26 12:03","pubTimestamp":1787717002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","TRUH","IYH","FHLC","AIPO","NVOC","MEDI","NVOX","AGIX","PINK","CHAT","THNR","CURE","NBDS","FXH","PJP","RSPH","VTHR","ARTY","XLVI","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660649212","title":"惠誉评级：美国医疗保健网络风险日益增加。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660649212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660649212?lang=zh_cn&edition=full","pubTime":"2026-08-19 04:43","pubTimestamp":1787085794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","FXH","HYLG","XLVI","BK4588","JHMH","CURE","BK4585","MOAT","IYH","PTH","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490484","title":"减肥药营销“战事”升级：从名人“代言”到老板下场，药企在焦虑什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490484","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660490484?lang=zh_cn&edition=full","pubTime":"2026-08-17 18:59","pubTimestamp":1786964340,"startTime":"0","endTime":"0","summary":"2026年以来，国内减肥药赛道的宣发动作愈发密集且新颖。8月16日，一场银屑病慢病管理公益计划在上海启动，活动聚焦于银屑病与肥胖的关系。背后的支持方是信达生物（1801.HK），该公司拥有已经获批的银屑病创新药匹康奇拜单抗，也手握国内明星GLP-1药物玛仕度肽。将其他疾病与肥胖话题关联起来，此次活动侧面打开了减肥药宣传的新思路。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843343562.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843343562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CURE","MEDI","FXH","RSPH","NVOC","TRUH","FHLC","IYH","THNR","NBDS","PJP","XLVI","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996687","title":"30周狂卖500万张！GLP-1引爆行情，减肥药口服时代来临","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996687","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996687?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:20","pubTimestamp":1786440001,"startTime":"0","endTime":"0","summary":"据开源证券研报，Wegovy口服片剂上市后处方量快速攀升，30周累计突破500万张，有效扩宽了GLP-1药物可及性边界，驱动减重产业链持续高景气。2026年被业内视作GLP-1减肥药的“口服元年”。产业链全面受益随着海外商业化落地持续超预期，全球GLP-1减重市场规模迎来指数级增长。口服GLP-1药物放量带动规模化生产需求激增，海外药企产能逐步承压，持续将生产环节外包至国内优质代工企业。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260811/32331742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["JDOC","FXH","GLP","NBDS","PINK","RSPH","THNR","XLVI","CURE","NVOC","BK4144","IYH","TRUH","PJP","MEDI","FHLC","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969925","title":"Hims & Hers Health次季亏损超预期，转向品牌减肥药导致成本上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969925","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969925?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:46","pubTimestamp":1786419965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TRUH","IYH","MEDI","RSPH","FHLC","PINK","PJP","CURE","THNR","NVOC","NBDS","XLVI","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657896386","title":"美国银行每年砸2.5亿美元支持员工使用GLP-1减肥药","url":"https://stock-news.laohu8.com/highlight/detail?id=2657896386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657896386?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:06","pubTimestamp":1786007162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BBT3K403.USD","LLII","IYH","LU0053666078.USD","LU1280957306.USD","RSPH","LU0170899867.USD","IE0001KFT4U8.USD","BK4534","LU0648001328.SGD","IE00BZ1G4Q59.USD","JDOC","LU0314106906.USD","NVOC","PINK","PJP","XLF","MEDI","BAC","GLP","LU1496350171.SGD","TRUH","IYF","FNCL","BK4588","FXH","NBDS","THNR","LU0980610538.SGD","IYG","XLVI","LU0106831901.USD","TFNS","KBWB","LU1506573853.SGD","ELIL","UYG","BK4590","VFH","LLYZ","LU0130103400.USD","ELIS","CURE","OZEM","FHLC","FTXO","LU0211331839.USD","PGF","IE00B19Z3B42.SGD","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657674945","title":"安进二季度强劲药品销售，上调预期，将终止早期减肥药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2657674945","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657674945?lang=zh_cn&edition=full","pubTime":"2026-08-05 05:11","pubTimestamp":1785877860,"startTime":"0","endTime":"0","summary":"　　$安进$公司于周二美股收盘后公布财报，第二季度强劲药品销售提振公司利润，因此上调了全年预期，但同时表示将终止一款早期减肥疗法的开发。　　这家生物技术公司周二表示，将停止AMG 513的开发，这是一款目前处于1期研究阶段的潜在减肥疗法。安进称，该研究将完成以跟踪已入组受试者。　　随着AMG 513开发的终止，安进在该领域唯一的候选药物是MariTide，该药目前正在进行针对肥胖、2型糖尿病和慢性体重管理等适应症的3期研究。","market":"us","thumbnail":"https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimezkz1673958.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2089984988.USD","BBH","RSPH","PJP","IE00B2B36J28.USD","CURE","BIB","IE0009355771.USD","LU1983299246.USD","BK4534","LU0058720904.USD","IE00BJJMRZ35.SGD","IYH","BK4588","LU2242646821.SGD","LU1023059063.AUD","PBE","PINK","THNR","BK4566","BK4581","BK4533","IE00B4R5TH58.HKD","LU0109394709.USD","LU0122379950.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","TBXU","MEDI","BK4139","IE00BJT1NW94.SGD","IBBQ","FXH","IBB","LU0889565916.HKD","IE0002141913.USD","LU1061106388.HKD","LU0289739699.SGD","NVOC","LU1571399168.USD","LU2468319806.SGD","LU0868494617.USD","LU0320765992.SGD","NBDS","BK4599","XLVI","TRUH","LU2242652126.USD","FHLC","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652726614","title":"A股减肥药板块低开高走，海正药业涨停，博腾股份涨超4%，翰宇药业、众生药业、皓元医药、恒瑞医药等个股跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2652726614","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652726614?lang=zh_cn&edition=full","pubTime":"2026-07-20 10:04","pubTimestamp":1784513089,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","MEDI","PINK","FXH","PJP","FHLC","IYH","NBDS","THNR","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651471109","title":"HCA医疗下调年度营收预期后，医院运营商股价集体下跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651471109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651471109?lang=zh_cn&edition=full","pubTime":"2026-07-14 21:37","pubTimestamp":1784036274,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0211328371.USD","LU0648001328.SGD","LU0310800379.SGD","IE00B775SV38.USD","LU1150488218.USD","XHS","CURE","LU0882574055.USD","LU0980610538.SGD","PINK","LU0985489474.SGD","LU1201861249.SGD","BK4185","LU0068578508.USD","LU0114720955.EUR","SG9999014039.USD","LU0203347892.USD","SG9999014013.SGD","LU0868494617.USD","LU1261432733.SGD","LU0310799852.SGD","BK4585","LU0130102774.USD","BK4504","LU0203345920.USD","LU1084165304.USD","LU0878866978.SGD","IHF","LU2244417387.USD","LU0708994859.HKD","LU2355687059.USD","LU0433182093.SGD","SG9999014021.USD","LU1119994496.HKD","LU1150488135.SGD","BK4588","LU1267930490.SGD","HCA","LU0128525929.USD","LU1489326972.SGD","SG9999014005.SGD","LU0211327993.USD","LU0029864427.USD","IE00B3S45H60.SGD","LU0187121727.USD","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651112380","title":"“笔帽”专利诉讼背后：减肥药带火百亿注射笔赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2651112380","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651112380?lang=zh_cn&edition=full","pubTime":"2026-07-13 21:23","pubTimestamp":1783948980,"startTime":"0","endTime":"0","summary":"一起“笔帽”专利纠纷，揭开GLP-1注射笔百亿市场的一角。7月10日，银诺医药（2591.HK）通过官方微信公众号发布情况说明，称公司作为被告涉及一起实用新型专利侵权诉讼，原告为苏州嘉树生物医疗科技有限公司（简称“苏州嘉树”），诉讼的核心问题不是银诺医药GLP-1产品依苏帕格鲁肽α注射液本身，而是产品配套使用的预充式注射笔中笔帽是否存在侵权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607133804157469.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607133804157469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ITAN","RSPH","MEDI","THNR","IYH","FHLC","CURE","PJP","NBDS","PINK","PATN","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115402","title":"创新医疗器械审批有了绿色通道 国产医疗器械为全球提供中国方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115402","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651115402?lang=zh_cn&edition=full","pubTime":"2026-07-13 19:05","pubTimestamp":1783940733,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","AGNG","RXD","HART","BMED","LGHT","IHI","IBRN","PSCH","PINK","RSPH","PTH","MEDX","XHE","FHLC","BK4585","GDOC","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651853167","title":"减肥药板块短线拉升，争光股份涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651853167","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651853167?lang=zh_cn&edition=full","pubTime":"2026-07-13 10:24","pubTimestamp":1783909464,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PINK","RSPH","FHLC","MEDI","FXH","PJP","NBDS","IYH","THNR","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650905908","title":"A股减肥药板块异动拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2650905908","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650905908?lang=zh_cn&edition=full","pubTime":"2026-07-10 10:00","pubTimestamp":1783648801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FXH","THNR","IYH","PJP","PINK","NBDS","RSPH","CURE","MEDI","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629786885","title":"Ju.com “第二轮 Meme 打新计划” 第 8 期 PINK 打新资金超 1 亿美金，今晚 8 点准时上线","url":"https://stock-news.laohu8.com/highlight/detail?id=2629786885","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629786885?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:17","pubTimestamp":1776932258,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，第 8 期项目 PINK 已于 4 月 23 日 16:00 结束认购，并将于 4 月 23 日 20:00 完成 TGE。本期活动参与人数超 5.3 万人，认购总金额 107,833,423 USDT。本期 PINK 认购资产结算后无锁仓，到账即为现货，用户可即时选择卖出或提现。\n\n本期延续多币种参与机制，用户可使用 JU / USDT / BTC / ETH 参与认购，平台将统一按 U 本位折算分配。本轮同步引入动态中签率模型，募集金额每增加 5,000,000 USDT，中签率增长 0.2%。成功邀请好友参与可瓜分最高 20% 最终发行量的 Token 奖励。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2260459","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629070115","title":"Ju.com “第二轮 Meme 打新计划” 第 7 期项目 CLOSE 正式上线，第 8 期 PINK 将于今日 16:00 开启认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2629070115","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629070115?lang=zh_cn&edition=full","pubTime":"2026-04-21 11:57","pubTimestamp":1776743839,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，第 7 期 CLOSE 已正式上线，本期中签率为 4.6%，上线价格 0.133 USDT，打新收益率 33%，整体资金收益率约 1.5 %。本期 CLOSE 认购资产结算后无锁仓，到账即为现货，用户可即时选择卖出或提现。\n\n第 8 期 PINK 将于今日 16:00 正式开启认购，至 4 月 23 日 16:00 结束。本期延续多币种参与机制，用户可使用 JU / USDT / BTC / ETH 参与认购，平台将统一按 U 本位折算分配。本轮同步引入动态中签率模型，募集金额每增加 5,000,000 USDT，中签率增长 0.2%。成功邀请好友参与可瓜分最高 20% 最终发行量的 Token 奖励。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2259950","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PINK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0232},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0494},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.2876},{"period":"ytd","weight":0.0729}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.01},{"period":"6month","weight":0.1181},{"period":"1year","weight":0.181},{"period":"ytd","weight":0.1171}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.012643},{"month":2,"riseRate":0.6,"avgChangeRate":0.005136},{"month":3,"riseRate":0.6,"avgChangeRate":-0.001509},{"month":4,"riseRate":0.6,"avgChangeRate":-0.008129},{"month":5,"riseRate":0.6,"avgChangeRate":0.008295},{"month":6,"riseRate":0.8,"avgChangeRate":0.032925},{"month":7,"riseRate":0.6,"avgChangeRate":0.011634},{"month":8,"riseRate":0.6,"avgChangeRate":0.002039},{"month":9,"riseRate":0.2,"avgChangeRate":-0.009884},{"month":10,"riseRate":0.5,"avgChangeRate":0.018501},{"month":11,"riseRate":0.8,"avgChangeRate":0.042023},{"month":12,"riseRate":0.4,"avgChangeRate":0.008788}],"exchange":"ARCA","name":"SIMPLIFY HEALTH CARE ETF","nameEN":"SIMPLIFY HEALTH CARE ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SIMPLIFY HEALTH CARE ETF(PINK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SIMPLIFY HEALTH CARE ETF(PINK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SIMPLIFY HEALTH CARE ETF,PINK,SIMPLIFY HEALTH CARE ETF股票,SIMPLIFY HEALTH CARE ETF股票老虎,SIMPLIFY HEALTH CARE ETF股票老虎国际,SIMPLIFY HEALTH CARE ETF行情,SIMPLIFY HEALTH CARE ETF股票行情,SIMPLIFY HEALTH CARE ETF股价,SIMPLIFY HEALTH CARE ETF股市,SIMPLIFY HEALTH CARE ETF股票价格,SIMPLIFY HEALTH CARE ETF股票交易,SIMPLIFY HEALTH CARE ETF股票购买,SIMPLIFY HEALTH CARE ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SIMPLIFY HEALTH CARE ETF(PINK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SIMPLIFY HEALTH CARE ETF(PINK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}